Skip to main content
A

AbClon Inc. — Investor Relations & Filings

Ticker · 174900 ISIN · KR7174900001 KO Manufacturing
Open in API
Filings indexed 252 across all filing types
Latest filing 2024-01-29 Earnings Release
Country KR South Korea
Listing KO 174900

About AbClon Inc.

https://www.abclon.com/en/

AbClon Inc. is a clinical-stage company focused on the research and development of antibody-based therapeutics. The company leverages three core proprietary platforms. The CAR-T platform develops personalized cell therapies for cancer patients by engineering a patient's own immune cells to target and destroy cancer cells, with a focus on blood cancers. The NEST (Novel Epitope Screening Technology) platform is designed to discover antibodies that target unique, previously unaddressed sites on disease proteins, enabling novel therapeutic effects. The AffiMab platform facilitates the development of bispecific antibodies that can simultaneously engage two different disease targets, aiming to maximize therapeutic efficacy in refractory diseases.

Recent filings

Filing Released Lang Actions
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 1% confidence The document is a regulatory filing from a Korean company (AbClon) announcing a significant change (over 30%) in revenue or profit/loss structure. This is a standard regulatory disclosure requirement in the Korean market (DART system) for listed companies to report preliminary financial results before the final audit report is finalized. Since it provides key financial highlights and reasons for the change, it fits the definition of an Earnings Release (ER). FY 2023
2024-01-29 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 1% confidence The document is a formal announcement regarding the scheduling and details of an Investor Relations (IR) meeting (기업설명회). It provides the date, location, purpose, and contact information for the event. Since it is an announcement of an upcoming event rather than the presentation materials themselves, and it serves as a regulatory notification of corporate activity, it fits best under the 'Regulatory Filings' (RNS) category as it is a standard disclosure of an IR event schedule.
2024-01-12 Korean
전환가액의조정
Capital/Financing Update Classification · 1% confidence The document is a formal regulatory filing from a Korean company (AbClon) regarding the adjustment of the conversion price of convertible bonds. It details the change in conversion price, the number of convertible shares, and the reason for the adjustment (issuance of new shares at a price below market value). This type of disclosure regarding capital structure and debt instrument terms falls under 'Capital/Financing Update'.
2023-12-22 Korean
증권발행결과(자율공시)
Share Issue/Capital Change Classification · 1% confidence The document is a 'Securities Issuance Result' (증권 발행결과) announcement from AbClon. It details the final outcome of a third-party allocation capital increase (유상증자), including the number of shares issued, the amount raised, and the payment date. This falls under the category of share issuance and capital changes.
2023-12-21 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 1% confidence The document is a short regulatory announcement regarding the setting of a record date and shareholder register closure period for an upcoming Annual General Meeting (AGM). It does not contain the full AGM materials or proxy statements, but rather serves as a formal regulatory notice of the procedural steps required for the meeting. Given the nature of the announcement as a regulatory filing regarding meeting logistics, it fits best under the RNS category.
2023-12-14 Korean
주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 1% confidence The document is a 'Major Matters Report' (주요사항보고서) from AbClon Inc. regarding a 'Decision on Paid-in Capital Increase' (유상증자결정). It details the issuance of new shares (third-party allocation), pricing, conversion rights, and the purpose of the capital raise. This falls under the category of announcements regarding new share issues or capital structure changes.
2023-12-13 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.